BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
8/10/20 Catalyst Pharmaceuticals (CPRX) Firdapse for Myasthenia Gravis (MG) Subscribers Only Subscribers Only Subscribers Only
8/10/20 Seres Therapeutics (MCRB) SER-109 for Clostridium difficile-Associated Diarrhea/Infection (CDAD/CDI) Subscribers Only Subscribers Only Subscribers Only
8/9/20 Roche (RHHBY) Etrolizumab for Ulcerative Colitis (UC) Subscribers Only Subscribers Only Subscribers Only
8/9/20 Roche (RHHBY) Etrolizumab for Ulcerative Colitis (UC) Subscribers Only Subscribers Only Subscribers Only
8/8/20 Xcovery Ensartinib for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
08/16/19 Subscribers Only Subscribers Only Partnership - Acquisition Completion
08/13/20 Subscribers Only Subscribers Only Regulatory - FDA Advisory Panel Meeting
08/14/20 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
Now - 08/15/20 Subscribers Only Subscribers Only Trial Announcement - Initiation
Now - 08/15/20 Subscribers Only Subscribers Only Regulatory - Meeting with FDA
Back to the top Back to the top